fda compounding semaglutide news november 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded GLP-1 medications Hims & Hers stock falls

GLP-1 visits happen in a Carrollwood medical office, not through a shipping-only app

Respect to Jon for putting the hard truth on the table

Statements Author contributions EP: Conceptualization, Funding acquisition, Supervision, Writing review & editing, Resources, Validation

Figure 10 In addition to the sulfonamides, e.g., 40 and 41 , the spiro-oxindole dihydroquinazolinone derivative 42 was identified in the screening campaign and subsequently a large series of related analogues were made, e.g., by applying rapid MW-assisted reactions and thereafter examined as IRAP inhibitors in bioassays (Engen et al., 2020) (Figure 10)